Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
Contenuto fornito da Jon Chee. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Jon Chee o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
🧬 Noam Solomon - Immunai - Part 3 | Deciphering the Book That is the Human Immune System | Building Immunai’s Team | The Importance of Single Cell Multi-Omics | Big Pharma & Dancing With Gorillas
Manage episode 435046537 series 3461709
Contenuto fornito da Jon Chee. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Jon Chee o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 3 of 4.
My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
Prior to co-founding Immunai, Noam had a career in both industry and academia. Noam has a double PhD in math and computer science and served as a postdoctoral researcher at MIT and Harvard. Noam also worked as an algorithms developer, consultant, and head of data science in several high-tech companies in Israel. Noam's extensive background in math, computer science, AI, and machine learning gives him a unique depth of experience that founders can learn from.
Join us this week and hear about:
- How the human genome project gave us the alphabet to read the book that is the human immune system
- Immunai’s philosophy of doing what's right even if they don’t know what they’re doing
- Balancing a CEO’s naivete with being selective about who’s advise to take
- What single cell multi-omics, the technology behind Immunai, really means
- Why working with different pharma companies is like dancing with a gorilla
Please enjoy my conversation with Noam Solomon.
Timestamps:
00:28 Intro
02:04 Episode starts, the human genome project and the alphabet used to read the book of the human immune system
05:10 Bringing an outsider's perspective to Immunai and their unique approach
08:07 Building the the Immunai team with both immunology and computer science experts who are not afraid to ask the stupid questions
12:10 Observing the hospital, pharma, AI landscape and how that shaped their philosophy of doing what's right even if they don’t know what they’re doing
19:00 Balancing both your naivete as a CEO with judging who’s advice to take
20:03 What is single cell multi-omics, the technology behind Immunai and what they learned from Netflix
24:44 How to embrace failure without creating a failure culture and other lessons learned from setting up their first lab
28:22 “Do you know how you dance with a gorilla?” and how to work with different pharma companies
33:05: Outro
Find Our Guest, Noam Solomon, at this link:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes:
Topics Mentioned:
Immunai https://www.immunai.com/
Human Genome Project https://www.genome.gov/human-genome-project
Single Cell Multi-Omics https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303816/
Recommender Systems https://en.wikipedia.org/wiki/Recommender_system
What Is Bioinformatics https://www.excedr.com/blog/what-is-bioinformatics-and-computational-biology
New Drug Application https://www.excedr.com/blog/new-drug-application-process
Guide to the FDA Drug Approval Process https://www.excedr.com/blog/fda-drug-approval-process-guide
Equipment Leasing for Laboratories https://www.excedr.com/leasing
Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support
People Mentioned:
Louis Voloch https://www.linkedin.com/in/luisvoloch
Ansuman Satpathy https://www.linkedin.com/in/ansuman-satpathy-3b386639/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
112 episodi
Manage episode 435046537 series 3461709
Contenuto fornito da Jon Chee. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Jon Chee o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 3 of 4.
My guest for this week’s episode is Noam Solomon, CEO and co-founder at Immunai, a pioneering biotech company that is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.
Prior to co-founding Immunai, Noam had a career in both industry and academia. Noam has a double PhD in math and computer science and served as a postdoctoral researcher at MIT and Harvard. Noam also worked as an algorithms developer, consultant, and head of data science in several high-tech companies in Israel. Noam's extensive background in math, computer science, AI, and machine learning gives him a unique depth of experience that founders can learn from.
Join us this week and hear about:
- How the human genome project gave us the alphabet to read the book that is the human immune system
- Immunai’s philosophy of doing what's right even if they don’t know what they’re doing
- Balancing a CEO’s naivete with being selective about who’s advise to take
- What single cell multi-omics, the technology behind Immunai, really means
- Why working with different pharma companies is like dancing with a gorilla
Please enjoy my conversation with Noam Solomon.
Timestamps:
00:28 Intro
02:04 Episode starts, the human genome project and the alphabet used to read the book of the human immune system
05:10 Bringing an outsider's perspective to Immunai and their unique approach
08:07 Building the the Immunai team with both immunology and computer science experts who are not afraid to ask the stupid questions
12:10 Observing the hospital, pharma, AI landscape and how that shaped their philosophy of doing what's right even if they don’t know what they’re doing
19:00 Balancing both your naivete as a CEO with judging who’s advice to take
20:03 What is single cell multi-omics, the technology behind Immunai and what they learned from Netflix
24:44 How to embrace failure without creating a failure culture and other lessons learned from setting up their first lab
28:22 “Do you know how you dance with a gorilla?” and how to work with different pharma companies
33:05: Outro
Find Our Guest, Noam Solomon, at this link:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes:
Topics Mentioned:
Immunai https://www.immunai.com/
Human Genome Project https://www.genome.gov/human-genome-project
Single Cell Multi-Omics https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303816/
Recommender Systems https://en.wikipedia.org/wiki/Recommender_system
What Is Bioinformatics https://www.excedr.com/blog/what-is-bioinformatics-and-computational-biology
New Drug Application https://www.excedr.com/blog/new-drug-application-process
Guide to the FDA Drug Approval Process https://www.excedr.com/blog/fda-drug-approval-process-guide
Equipment Leasing for Laboratories https://www.excedr.com/leasing
Biotech Startup Support https://www.excedr.com/resources-category/biotech-startup-support
People Mentioned:
Louis Voloch https://www.linkedin.com/in/luisvoloch
Ansuman Satpathy https://www.linkedin.com/in/ansuman-satpathy-3b386639/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
112 episodi
Todos los episodios
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.